Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 22:58:34 UTC |
---|
Update Date | 2021-09-26 22:54:40 UTC |
---|
HMDB ID | HMDB0245930 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one |
---|
Description | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one, also known as 3-methylclonazepam, belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. Based on a literature review a significant number of articles have been published on 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one. This compound has been identified in human blood as reported by (PMID: 31557052 ). 5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(=C2)[N+]([O-])=O InChI=1S/C16H12ClN3O3/c1-9-16(21)19-14-7-6-10(20(22)23)8-12(14)15(18-9)11-4-2-3-5-13(11)17/h2-9H,1H3,(H,19,21) |
---|
Synonyms | Value | Source |
---|
3-Methylclonazepam | HMDB | Meclonazepam | HMDB | Meclonazepam, (R)-isomer | HMDB | Meclonazepam, (S)-isomer | HMDB |
|
---|
Chemical Formula | C16H12ClN3O3 |
---|
Average Molecular Weight | 329.74 |
---|
Monoisotopic Molecular Weight | 329.056719 |
---|
IUPAC Name | 5-(2-chlorophenyl)-3-methyl-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one |
---|
Traditional Name | 5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(=C2)[N+]([O-])=O |
---|
InChI Identifier | InChI=1S/C16H12ClN3O3/c1-9-16(21)19-14-7-6-10(20(22)23)8-12(14)15(18-9)11-4-2-3-5-13(11)17/h2-9H,1H3,(H,19,21) |
---|
InChI Key | LMUVYJCAFWGNSY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- Nitroaromatic compound
- Halobenzene
- Chlorobenzene
- Benzenoid
- Monocyclic benzene moiety
- Aryl halide
- Aryl chloride
- Organic nitro compound
- Secondary carboxylic acid amide
- C-nitro compound
- Lactam
- Ketimine
- Carboxamide group
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Allyl-type 1,3-dipolar organic compound
- Organic oxoazanium
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organic zwitterion
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Imine
- Carbonyl group
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one,1TMS,isomer #1 | CC1N=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C2N([Si](C)(C)C)C1=O | 2697.7 | Semi standard non polar | 33892256 | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one,1TMS,isomer #1 | CC1N=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C2N([Si](C)(C)C)C1=O | 2728.7 | Standard non polar | 33892256 | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one,1TMS,isomer #1 | CC1N=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C2N([Si](C)(C)C)C1=O | 3941.1 | Standard polar | 33892256 | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one,1TBDMS,isomer #1 | CC1N=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 2905.2 | Semi standard non polar | 33892256 | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one,1TBDMS,isomer #1 | CC1N=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 2919.3 | Standard non polar | 33892256 | 5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one,1TBDMS,isomer #1 | CC1N=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 3960.6 | Standard polar | 33892256 |
|
---|